Psychiatric Mental Health Nurse Practitioner, PMHNP-BC

Hightop Health

. Conduct comprehensive psychiatric evaluations and assessments of patients .

Posted 11/4/2026full-timeCartersville • Georgia • United StatesJunior💰 $140,000 - $160,000 per yearWebsite

Core Competencies

Role fit

Core Competencies

Use this summary to align your resume positioning with the role.

Demonstrates expertise in conducting psychiatric evaluations, diagnosing mental illnesses, and developing personalized treatment plans. Proficient in collaborating with healthcare professionals and managing psychiatric medications while ensuring patient education and support.

Highest-signal resume keywords

Board-Certified Psychiatric Mental Health Nurse PractitionerGeorgia State LicenseExperience With Mental Health AssessmentKnowledge Of Psychiatric DisordersExperience With Athena (EHR)

ATS Keywords

Tailor your resume

Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard Skills

Psychiatric EvaluationsDiagnosis Of Mental IllnessesTreatment Plan DevelopmentMedication PrescriptionCrisis ManagementInterventional Treatments SupervisionLaboratory AssessmentsClinical Outcome Measurement ReviewUtilization Management PrinciplesTriage Management

Soft Skills

Strong Interpersonal SkillsAttention To DetailCollaboration With Multidisciplinary Team

Certifications & Qualifications

Board CertificationActive DEA

Industry Keywords

Mental Health ConditionsCo-Morbid Substance MisuseMajor Depressive DisorderBipolar IllnessesADHDAnxiety DisordersIV KetamineEsketamine (Spravato)IOP ProgrammingOutpatient Setting

About the role

Key responsibilities & impact

Conduct comprehensive psychiatric evaluations and assessments of patients
Diagnose and treat mental illnesses and disorders including major depressive disorder, bipolar illnesses, ADHD, anxiety disorders, and co-morbid substance misuse
Develop, implement, and monitor personalized treatment plans
Regularly assess and document patient progress and adjust treatment plans to optimize outcomes
Refer and supervise interventional treatments including TMS, Esketamine (Spravato), and IV Ketamine
Refer patients requiring intensive psychotherapy to IOP programming as indicated
Prescribe medications and monitor effectiveness, side effects, and patient preferences
Provide support and education to patients and families regarding mental health conditions and treatment options
Collaborate with psychiatrists, psychologists, therapists, and other healthcare professionals to coordinate comprehensive care
Order laboratory assessments, diagnostic tests, and specialty consultations
Review clinical outcome measurement data and use objective and subjective results to modify treatment plans

Requirements

What you’ll need

Minimum of 1 year of experience as a Board-Certified Psychiatric Mental Health Nurse Practitioner in an outpatient setting
Must have a Georgia state license and active DEA
Board Certification
Experience with mental health assessment, diagnosis, triage, managing common psychiatric medication and treatment plans, and managing crisis situations in an outpatient setting
Experience working with Athena (EHR) preferred
Understanding of utilization management principles
In-depth knowledge of psychiatric disorders and treatment modalities
Excellent diagnostic skills and ability to develop effective treatment plans
Strong interpersonal skills and willingness to collaborate with a multidisciplinary team and incorporate constructive recommendations
Attention to detail and ability to maintain accurate, timely records

Benefits

Comp & perks

Choose between 2 competitive compensation models
Comprehensive benefits including flexible PTO, medical, dental, vision, and life insurance
Pet insurance
401k match
$1500 yearly CME reimbursement
Malpractice insurance with tail
State-of-the-art EHR with AI-assisted note writing and integrated psychological assessments
Comprehensive Treatment Resistant Depression Program (TRD) training during onboarding
Research-driven practice with Phase II–IV psychopharmacology studies